8-Bromo-5-chloro-1,2,4-triazolo[4,3-a]pyridine, 1g

2-(2-methyl-1H-indol-3-yl)-N-(thiophen-2-ylmethyl)ethan-1-amine hydrochloride, 95.0%, 500mg

2-(3,5-Dimethyl-1-phenyl-1H-pyrazol-4-yl)acetic acid, 95.0%, 100mg

Ethyl 6-chloro-5-methylpicolinate, 95.0%, 500mg

N-Butylbenzenesulfonamide, 95.0%, 500g

GlcNAc beta(1-3)[GlcNAc beta(1-6)]GalNAc-alpha-Thr>94.0%(HPLC)2mg

(S)-11-Benzyl-1-(9H-fluoren-9-yl)-3,6,9,12,15-pentaoxo-2,18-dioxa-4,7,10,13,16-pentaazaicosan-20-oic acid, 98%, 250mg

5-(4-methyl-2-thienyl)-1,3,4-oxadiazol-2-amine, 95.0%, 500mg

(R)-1-(4-Morpholinophenyl)ethan-1-ol, 98%, 1g

5-Bromo-2-trifluoromethoxypyridine, 95.0%, 500mg

(3-(n-(Tert-butyl)sulfamoyl)-4-methoxyphenyl)boronic acid, 98%, 1g

8-Iodo-3-nitro-1-naphthoic acid, 98%, 250mg

2-Sulfobenzaldehyde Sodium Salt>98.0%(HPLC)(T)25g